Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis - PubMed (original) (raw)

Case Reports

. 2009 Dec 3;361(23):2296-7.

doi: 10.1056/NEJMc0910060. Epub 2009 Nov 11.

• PMID: 19907034
• DOI: 10.1056/NEJMc0910060

Case Reports

Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis

Mariana Baz et al. N Engl J Med. 2009.

No abstract available

PubMed Disclaimer

Similar articles

• First isolation of a oseltamivir-resistant influenza A (H1N1) strain in Argentina.
  Cané A, Casanueva E, Iolster T, Sticco N, Richards L, Sosa P, Pontoriero A, Avaro M, Zcech A, Carabajal E, Campos A, Baumeister E, Diez MA, Rojas M, Rivarola MR. Cané A, et al. Pediatr Infect Dis J. 2010 Apr;29(4):384. doi: 10.1097/INF.0b013e3181cd7244. Pediatr Infect Dis J. 2010. PMID: 20351531 No abstract available.
• Global transmission of oseltamivir-resistant influenza.
  Moscona A. Moscona A. N Engl J Med. 2009 Mar 5;360(10):953-6. doi: 10.1056/NEJMp0900648. Epub 2009 Mar 2. N Engl J Med. 2009. PMID: 19258250 No abstract available.
• Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus.
  van der Vries E, Stelma FF, Boucher CA. van der Vries E, et al. N Engl J Med. 2010 Sep 30;363(14):1381-2. doi: 10.1056/NEJMc1003749. N Engl J Med. 2010. PMID: 20879894 No abstract available.
• Emerging oseltamivir resistance in seasonal and pandemic influenza A/H1N1.
  Renaud C, Kuypers J, Englund JA. Renaud C, et al. J Clin Virol. 2011 Oct;52(2):70-8. doi: 10.1016/j.jcv.2011.05.019. Epub 2011 Jun 17. J Clin Virol. 2011. PMID: 21684202 Review.
• [Drug-resistant influenza viruses: an overview].
  Hatakeyama S. Hatakeyama S. Nihon Rinsho. 2010 Sep;68(9):1671-8. Nihon Rinsho. 2010. PMID: 20845746 Review. Japanese.

Cited by

• Drug resistance and possible therapeutic options against influenza A virus infection over past years.
  Raza MA, Ashraf MA. Raza MA, et al. Arch Microbiol. 2024 Nov 5;206(12):458. doi: 10.1007/s00203-024-04181-3. Arch Microbiol. 2024. PMID: 39499323 Review.
• AMMI Canada 2023 update on influenza: Management and emerging issues.
  Harrison R, Mubareka S, Papenburg J, Schober T, Allen UD, Hatchette TF, Evans GA. Harrison R, et al. J Assoc Med Microbiol Infect Dis Can. 2023 Nov 29;8(3):176-185. doi: 10.3138/jammi-2023-07-12. eCollection 2023 Nov. J Assoc Med Microbiol Infect Dis Can. 2023. PMID: 38058499 Free PMC article. No abstract available.
• Multicenter, randomized controlled, open label evaluation of the efficacy and safety of arbidol hydrochloride tablets in the treatment of influenza-like cases.
  Bai X, Xi S, Chen G, Fan X, Wang K, Li Y, Zhao Y, Wang W, Tian Y. Bai X, et al. BMC Infect Dis. 2023 Sep 6;23(1):585. doi: 10.1186/s12879-023-08570-9. BMC Infect Dis. 2023. PMID: 37674112 Free PMC article. Clinical Trial.
• Influenza antivirals and their role in pandemic preparedness.
  Jones JC, Yen HL, Adams P, Armstrong K, Govorkova EA. Jones JC, et al. Antiviral Res. 2023 Feb;210:105499. doi: 10.1016/j.antiviral.2022.105499. Epub 2022 Dec 23. Antiviral Res. 2023. PMID: 36567025 Free PMC article. Review.
• The effect of statins on the prevalence and mortality of influenza virus infection: a systematic review and meta-analysis.
  Vahedian-Azimi A, Mannarino MR, Shojaie S, Rahimibashar F, Galeh HEG, Banach M, Bianconi V, Pirro M, Sahebkar A. Vahedian-Azimi A, et al. Arch Med Sci. 2022 Nov 7;18(6):1513-1524. doi: 10.5114/aoms/149633. eCollection 2022. Arch Med Sci. 2022. PMID: 36457966 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information